FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/103947 [Registered on: 16/02/2026] Trial Registered Prospectively
Last Modified On: 13/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Prospective Observational 
Study Design  Other 
Public Title of Study   A Prospective study on reasons for Admission, Symptoms and Proportion of discharge in Advanced Cancer patients admitted in Palliative Care Ward 
Scientific Title of Study   OUTCOMES, REASONS OF ADMISSIONS AND SYMPTOM PROFILE OF ADVANCED CANCER PATIENTS ADMITTED IN AN INPATIENT PALLIATIVE CARE UNIT IN TERTIARY CANCER CENTRE IN LOW- MIDDLE-INCOME COUNTRY- A PROSPECTIVE OBSERVATIONAL STUDY 
Trial Acronym  Nil  
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Jayita Deodhar 
Designation  Professor and Head  
Affiliation  Tata Memorial Hospital ,Mumbai  
Address  Room no 132, MB 75 ,Department of Palliative medicine
Tata Memorial Hospital , Parel ,Mumbai 400012
Mumbai
MAHARASHTRA
400012
India 
Phone  9892358023  
Fax    
Email  jukd2000@yahoo.co.uk  
 
Details of Contact Person
Scientific Query  
Name  Dr Dipa Amte  
Designation  Junior Resident  
Affiliation  Tata Memorial Hospital ,Mumbai  
Address  Room no 132, MB 75 ,Department of Palliative medicine
Tata Memorial Hospital , Parel ,Mumbai, 400012
Mumbai
MAHARASHTRA
400012
India 
Phone  8830957087   
Fax    
Email  dipaamte05@gmail.com   
 
Details of Contact Person
Public Query  
Name  Dr Jayita Deodhar 
Designation  Professor and Head  
Affiliation  Tata Memorial Hospital ,Mumbai  
Address  Room no 132, MB 75 ,Department of Palliative medicine
Tata Memorial Hospital , Parel ,Mumbai 400012
Mumbai
MAHARASHTRA
400012
India 
Phone  9892358023  
Fax    
Email  jukd2000@yahoo.co.uk  
 
Source of Monetary or Material Support  
Tata Memorial Hospital, Dr E. Borges Road ,Parel, Mumbai - 400012  
 
Primary Sponsor  
Name  NIL 
Address  NIL 
Type of Sponsor  Other [NIL] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jayita Deodhar   Tata Memorial Hospital  Room no 132 , Main building 75 no OPD , Tata Memorial Hospital, E.Borges Road ,Parel ,Mumbai 400012
Mumbai
MAHARASHTRA 		 9892358023

jukd2000@yahoo.co.uk 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE I  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C00-D49||Neoplasms,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1. Patients diagnosed with advanced cancer admitted to the Inpatient Palliative Care Unit (IPCU).
2. Age more than or equal to 18 years.
3. Able to communicate and understand English, Hindi, or Marathi, and willing to provide informed consent.
4. If a patient is unable to provide consent, consent is obtained from a legally authorized representative (LAR). 
 
ExclusionCriteria 
Details  None  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Proportion of patients discharged from the Inpatient Palliative Care Unit (IPCU).  At the time of discharge . 
 
Secondary Outcome  
Outcome  TimePoints 
Reasons for Admission: Frequency and percentage of reasons for IPCU
admission as documented in patient admission notes or electronic medical records
(EMR). 		 Day 0  
Symptom Burden at Admission: Frequency and percentage of symptoms at the time of admission, assessed using the ESAS-r scale.  Day 0 
Symptom Change Over Time: Change in symptom severity scores on day 3 and at discharge compared with baseline (day 0), measured using ESAS-r scores.  Day 0, day 3 and discharge 
Investigations Performed: Frequency and percentage of diagnostic investigations conducted during IPCU admission as per inpatient records or EMR documentation.  Day 0 till discharge 
Medications Used: Frequency and percentage of various medications administered during the IPCU stay based on inpatient records or EMR documentation.  Day 0 till discharge 
Medical Procedures performed : Frequency and percentage of medical
procedures performed during IPCU admission as per inpatient records or EMR. 		 Day 0 till discharge 
Referrals given :Frequency and percentage referrals with support services (e.g., physiotherapy, occupational therapy, dietetics, psychology) during the IPCU stay, as documented in the records or EMR.  Day 0 till discharge 
Length of Stay: Median duration (in days) of IPCU hospitalization, as
recorded in inpatient records or EMR. 		 Day 0 till discharge 
Post-discharge Survival: Number and percentage of patients surviving 30
days post-discharge, assessed through telephonic follow-up. 		 30 days post-discharge 
Predictive Factors for Survival: Analysis of associations between baseline
demographic, clinical, and treatment-related variables (such as age, performance
status, and type of malignancy) and overall post-discharge survival. 		 Day 0 till discharge 
 
Target Sample Size   Total Sample Size="55"
Sample Size from India="55" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   27/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This is a single-centre, prospective observational study conducted at the Inpatient Palliative Care Unit (IPCU) of Tata Memorial Hospital, Mumbai. The study aims to assess the outcomes, reasons for admission, and symptom profile of adult patients with advanced cancer admitted to the IPCU over a 12-month period.

A minimum of 55 patients will be enrolled. Symptom burden will be assessed using the Edmonton Symptom Assessment Scale–Revised (ESAS-r) at admission (Day 0), Day 3, and at discharge. The primary outcome is the proportion of patients discharged from the IPCU. Secondary outcomes include reasons for admission, symptom changes during hospitalization, investigations performed, medications used, procedures conducted, length of stay, and 30-day post-discharge survival (assessed via telephonic follow-up).

This study addresses a significant gap in Indian palliative care research by prospectively evaluating IPCU admissions and outcomes in a low- and middle-income country setting, with the goal of improving resource planning and quality of care delivery.

 
Close